EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect

Abdul Majid, Fasilat Oluwakemi Hassan, Md Monirul Hoque iD, Joy Olaoluwa Gbadegoye, Djamel Lebeche iD

Journal of Cardiovascular Development and Disease · 21.07.2023 · 10 (7) · 313

DOI: 10.3390/jcdd10070313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 21.07.2023. Verfasst von Abdul Majid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, The University of Tennessee Health Science Center, Translational Research Building, Room 318H, 71 S. M…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis is a pathological condition characterized by excessive deposition of collagen and other extracellular matrix components in the heart. It is recognized as a major contributor to the development and progression of heart failure. Despite significant research efforts in characterizing and identifying key molecular mechanisms associated with myocardial fibrosis, effective treatment for this condition is still out of sight. In this regard, bioactive compounds have emerged as potential therapeutic antifibrotic agents due to their anti-inflammatory and antioxidant properties. These compounds exhibit the ability to modulate fibrogenic processes by inhibiting the production of extracellular matrix proteins involved in fibroblast to myofibroblast differentiation, or by promoting their breakdown. Extensive investigation of these bioactive compounds offers new possibilities for preventing or reducing cardiac fibrosis and its detrimental consequences. This comprehensive review aims to provide a thorough overview of the mechanisms underlying cardiac fibrosis, address the limitations of current treatment strategies, and specifically explore the potential of bioactive compounds as therapeutic interventions for the treatment and/or prevention of cardiac fibrosis.

Schlagwörter

Stichwörter der Autor:innen

bioactive compoundscardiac fibrosiscellular mechanismstreatments

Autor:innen und Institutionen

  • Department of Physiology, College of Medicine, The University of Tennessee Health Science Center, Translational Research Building, Room 318H, 71 S. Manassas, Memphis, TN 38163, USA.
  • College of Graduate Health Sciences, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Md Monirul Hoque, Djamel Lebeche

Zitieren

APA

Majid, A., Hassan, F. O., Hoque, M. M., Gbadegoye, J. O., & Lebeche, D. (2023). Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect. Journal of Cardiovascular Development and Disease, 10(7), 313. https://doi.org/10.3390/jcdd10070313

Vancouver

Majid A, Hassan FO, Hoque MM, Gbadegoye JO, Lebeche D. Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect. Journal of Cardiovascular Development and Disease. 2023;10(7):313. doi:10.3390/jcdd10070313

BibTeX
@article{Majid2023,
  author = {Majid, Abdul and Hassan, Fasilat Oluwakemi and Hoque, Md Monirul and Gbadegoye, Joy Olaoluwa and Lebeche, Djamel},
  title = {Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2023},
  volume = {10},
  number = {7},
  pages = {313},
  doi = {10.3390/jcdd10070313}
}
Kostenlos starten →